Andy H Hung1, Laura M Lilley1, Fengqin Hu2, Victoria S R Harrison1, Thomas J Meade1. 1. Department of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, Evanston, Illinois, USA. 2. College of Chemistry, Beijing Normal University, Beijing, China.
Abstract
PURPOSE: To demonstrate a new MR imaging approach that unambiguously identifies and quantitates contrast agents based on intrinsic agent properties such as r1 , r2 , r2*, and magnetic susceptibility. The approach is referred to as magnetic barcode imaging (MBI). METHODS: Targeted and bioresponsive contrast agents were imaged in agarose phantoms to generate T1 , T2 , T2*, and quantitative susceptibility maps. The parameter maps were processed by a machine learning algorithm that is trained to recognize the contrast agents based on these parameters. The output is a quantitative map of contrast agent concentration, identity, and functional state. RESULTS: MBI allowed the quantitative interpretation of intensities, removed confounding backgrounds, enabled contrast agent multiplexing, and unambiguously detected the activation and binding states of bioresponsive and targeted contrast agents. CONCLUSION: MBI has the potential to overcome significant limitations in the interpretation, quantitation, and multiplexing of contrast enhancement by MR imaging probes. Magn Reson Med 77:970-978, 2017.
PURPOSE: To demonstrate a new MR imaging approach that unambiguously identifies and quantitates contrast agents based on intrinsic agent properties such as r1 , r2 , r2*, and magnetic susceptibility. The approach is referred to as magnetic barcode imaging (MBI). METHODS: Targeted and bioresponsive contrast agents were imaged in agarose phantoms to generate T1 , T2 , T2*, and quantitative susceptibility maps. The parameter maps were processed by a machine learning algorithm that is trained to recognize the contrast agents based on these parameters. The output is a quantitative map of contrast agent concentration, identity, and functional state. RESULTS: MBI allowed the quantitative interpretation of intensities, removed confounding backgrounds, enabled contrast agent multiplexing, and unambiguously detected the activation and binding states of bioresponsive and targeted contrast agents. CONCLUSION: MBI has the potential to overcome significant limitations in the interpretation, quantitation, and multiplexing of contrast enhancement by MR imaging probes. Magn Reson Med 77:970-978, 2017.
Authors: A Y Louie; M M Hüber; E T Ahrens; U Rothbächer; R Moats; R E Jacobs; S E Fraser; T J Meade Journal: Nat Biotechnol Date: 2000-03 Impact factor: 54.908
Authors: Tian Liu; Pascal Spincemaille; Ludovic de Rochefort; Richard Wong; Martin Prince; Yi Wang Journal: Magn Reson Imaging Date: 2010-08-04 Impact factor: 2.546
Authors: Diego Alberti; Mark van't Erve; Rachele Stefania; Maria Rosaria Ruggiero; Marta Tapparo; Simonetta Geninatti Crich; Silvio Aime Journal: Angew Chem Int Ed Engl Date: 2014-02-24 Impact factor: 15.336
Authors: Lauren M Matosziuk; Jonathan H Leibowitz; Marie C Heffern; Keith W MacRenaris; Mark A Ratner; Thomas J Meade Journal: Inorg Chem Date: 2013-06-18 Impact factor: 5.165
Authors: Dan Ma; Vikas Gulani; Nicole Seiberlich; Kecheng Liu; Jeffrey L Sunshine; Jeffrey L Duerk; Mark A Griswold Journal: Nature Date: 2013-03-14 Impact factor: 49.962
Authors: Christian E Anderson; Shannon B Donnola; Yun Jiang; Joshua Batesole; Rebecca Darrah; Mitchell L Drumm; Susann M Brady-Kalnay; Nicole F Steinmetz; Xin Yu; Mark A Griswold; Chris A Flask Journal: Sci Rep Date: 2017-08-16 Impact factor: 4.379
Authors: George J Lu; Arash Farhadi; Jerzy O Szablowski; Audrey Lee-Gosselin; Samuel R Barnes; Anupama Lakshmanan; Raymond W Bourdeau; Mikhail G Shapiro Journal: Nat Mater Date: 2018-02-26 Impact factor: 43.841